IEEE 1708-2025 Overview: Study Design for Cuffless Blood Pressure Technologies

Why IEEE 1708-2025 Matters for Cuffless Blood Pressure Validation 

Cuffless blood pressure technology is advancing quickly, and credible performance claims depend on well-designed clinical validation studies. Unlike traditional cuff-based monitors, wearable and cuffless devices may use sensors, algorithms, calibration methods, or continuous signal processing to estimate blood pressure. 

IEEE 1708-2025 establishes an evaluation framework for wearable cuffless blood pressure measuring devices. The standard applies to devices with different measurement modes, including snapshot, continuous, beat-to-beat, and blood pressure variability measurements. 

For cuffless device developers, this creates a structured approach for planning validation studies, selecting reference methods, and defining participant enrollment requirements. 

Reference Measurements: Dual Auscultation or Arterial Line 

Reference method selection depends on the type of cuffless blood pressure output being evaluated. 

For snapshot cuffless BP devices, dual auscultation is commonly used as the reference method. This approach uses trained observers to collect reference blood pressure measurements under controlled conditions. 

For beat-to-beat or continuous blood pressure devices, arterial line blood pressure measurements may be used as the reference method. This approach provides waveform-level data that can be compared with device outputs for systolic, diastolic, and mean arterial pressure measurements.

Selecting the correct reference method is one of the most important parts of cuffless blood pressure study design because it determines how device performance will be evaluated. 

Sample Size and Study Structure 

IEEE 1708-2025 uses a structured approach to validation. The study design may include an initial assessment phase followed by a larger validation phase. 

The main validation plan may include several test components, depending on the device design and calibration approach: 

• Static performance testing  

• Testing after blood pressure change  

• Testing after a defined period of use  

  
  

Which components apply may depend on whether the device uses personalized calibration, population-based calibration, hybrid calibration, or a calibration-free approach. 

Blood Pressure Distribution and Participant Requirements 

Cuffless blood pressure validation studies must be designed so that results are not limited to a narrow group of participants or only normotensive blood pressure ranges. 

IEEE 1708-2025 specifies an age range of 21 to 50 years and a balanced distribution of female and male participants. Enrollment is structured to include participants across defined blood pressure classifications, with minimum targets for each category: 

• Normal  

• Elevated  

• Stage 1 hypertension  

• Stage 2 hypertension  

Special Populations and Confounding Factors 

IEEE 1708-2025 calls for separate studies aligned to the intended-use population. These populations may include adults over 51 years of age, pediatric participants, pregnant participants, individuals with arrhythmias, or participants using medications that may affect cardiovascular measurements. 

This is particularly relevant for cuffless devices because calibration approaches and physiological characteristics can differ across populations. 

How This Standard Differs From ISO 81060-2 

ISO 81060-2 is built around intermittent automated cuff-based measurements and a corresponding reference approach. IEEE 1708-2025 is tailored to cuffless and wearable technologies, including distinct reference methods for snapshot versus beat-to-beat devices and a two-phase enrollment structure with prespecified BP category coverage. 

Because cuffless devices rely on different measurement principles, their validation studies require different planning considerations, including reference method selection, calibration approach, time alignment, and performance evaluation across defined use conditions. 

Conclusion 

Parameters Research Laboratory supports cuffless blood pressure validation studies by designing clinical protocols around reference integrity, prespecified recruitment distributions, time alignment, and reproducible documentation. 

Depending on the device output and study objectives, studies may include dual auscultation or arterial line reference measurements. Protocol development, study conduct, and documentation are managed under IRB oversight and GCP/ISO 14155-aligned workflows to support clear performance interpretation and regulator-ready reporting. 

Ready to discuss your study? Contact us today!